USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook.
Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA), a global leader in direct selling, today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026.
“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,”
said Kevin Guest, Chairman and Chief Executive Officer.
“We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”
Key Financial and Operating Results
Q4 2025
Q4 2024
FY 2025
FY 2024
Net sales
$226.2
$213.6
$925.3
$854.5
Net (loss) earnings*
$-1.8
$4.5
$10.8
$42.0
Diluted EPS
$-0.10
$0.23
$0.58
$2.19
Adjusted diluted EPS(1)
$0.60
$0.64
$1.93
$2.59
Adjusted EBITDA(2)
$27.3
$25.5
$101.3
$110.3
USANA Active Customers
387,000
454,000
387,000
454,000
Hiya Active Monthly Subscribers
181,700
N/A
181,700
N/A
*Pretax earnings for Q4 2025 totaled $4.0 million with income tax expense of $5.8 million. The adjustment to income taxes during the period, largely as a result of one-time impairment and cost realignment charges, is about $3.1 million greater than what would have been expected using the previously expected 65% tax rate.
Net sales, Net (loss) earnings and Adjusted EBITDA figures